| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |